HHRI News & Press Releases
HHRI Publications – 2020
Home » Newsroom » HHRI Publications – 2020 Aby ES, Rodin H, Debes JD. Proton pump inhibitors and mortality in individuals with COVID-19. Am J Gastroenterol 2020;115(11):1918. Aby ES, Sultan A, Bane A, Wondifraw Z, Debes JD. Outcomes of sorafenib therapy in advanced hepatocellular carcinoma in a single center in…
Read More
Medication Access for Opioid Use Disorder Lower Among Those Involved with Criminal Justice System
Medicaid Expansion Helped Increase Access to Medications for Opioid Use Disorder, but Limitations Exist to Broadening Access. Approximately 6.5 million people are under correctional supervision in the United States on any given day. Justice-involved individuals (people currently or recently in prison or jail, on probation or parole, or arrested) experience…
Read MoreGrant Awards – 1st Qtr 2021
Home » Newsroom » Grant Awards – 1st Qtr 2021 Jason Baker – An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19, a.k.a. Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC), INSIGHT Protocol…
Read More
Dr. Johansen Receives NKF J. Michael Lazarus Award for Dedication to Kidney Health
Each year the National Kidney Foundation (NKF) considers the work of hundreds of specialists in the field of nephrology and selects among them those who most exemplify the relentless efforts of NKF to enhance the lives of patients through action, education, and accelerating change. NKF presents this award each year to…
Read More
What a Kidney Transplant Means for You or a Loved One
HHRI investigators Warren McKinney, PhD, and Ajay Israni, MD, MS, were guests on the African American Leadership Forum’s (AALF) Black Leadership Re-Defined radio show and podcast series on KMOJ (89.9FM) radio on March 7. They joined host Sylvia Bartley, PhD, to discuss the intricacies of kidney transplantation as well as…
Read More
Walz, Flanagan Announce Groundbreaking Partnership Between State of Minnesota, Health Care Systems on Race and Ethnicity Data Collection
— State announces additional, targeted strategies to promote equity in vaccination — The Walz-Flanagan Administration announced publication of vaccination data by race and ethnicity made possible through the groundbreaking partnership between the State of Minnesota and the Minnesota Electronic Health Record (EHR) Consortium. This unique and innovative collaboration between public…
Read More
Dr. Bart talks about meth addiction and treatment on Healthy Matters on WCCO radio
Hennepin Healthcare physician and HHRI investigator Dr. Gavin Bart was Dr. David Hilden’s guest Healthy Matters on WCCO 830-AM radio on Sunday, January 24, talking about meth addiction and treatment. Methamphetamine use is increasing across the country and in Minnesota has surpassed opioid use as a leading cause (behind only…
Read More
Breaking Through the Wall of Stigma in Healthcare
Stigma is a huge barrier for people with opioid use disorder and is particularly problematic in healthcare. In a series of NIH videos, Gavin Bart, MD, PhD, talks about the stigma in healthcare around substance use disorders, barriers to treatment, and empowering people and humanizing addiction. Read more about…
Read MoreGrant Awards – 3rd Qtr 2020
Home » Newsroom » Grant Awards – 3rd Qtr 2020 Casey Dorr – Developmental and Functional Characterization, by Tacrolimus Metabolism Assays, of CYP35A, University of Minnesota Ajay Israni – Forcasting Lung Transplant Benefit: A Dynamic Risk Modeling Approach, Cleveland Clinic Sandra Japuntich – Bupropion for the Prevention of Postpartum Relapse,…
Read More
HHRI Awarded Continuation of SRTR Contract
Minneapolis, Minn. – The Chronic Disease Research Group (CDRG) of the Hennepin Healthcare Research Institute (HHRI) has renewed its federal contract to operate the Scientific Registry of Transplant Recipients (SRTR). Among its key functions, the SRTR evaluates the status of the nation’s solid organ transplant system and provides analytic support to…
Read More
Hennepin Healthcare takes a pulse of the pandemic
by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…
Read More
New website offers added decision support for kidney and liver transplant candidates searching for a transplant center
Minneapolis, Minn. – Transplant candidates face obstacles in finding a transplant program that transplants patients like them. A new online tool developed by researchers at Hennepin Healthcare Research Institute (HHRI) and the University of Minnesota (UMN) is helping to remove those barriers. The website transplantcentersearch.org allows patients to conduct searches…
Read More
Hennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients
Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…
Read More
Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read More
Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19
Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Hennepin Healthcare is a clinical site…
Read More
Exploratory study identifies key factors associated with time pressure in primary care clinicians
Physicians often feel pressed for time during the standard primary care visit. Recent studies have shown that shorter visits are not only common but also lead to unaddressed health issues and a diminished understanding of patient concerns. Thus, it is critical to understand the relationship between time pressure, worklife factors…
Read MoreGrant Awards – 2019
Our Research Home » Newsroom » Grant Awards – 2019 Baker, Jason – PrEP IT: A Pilot Test of a Mobile Peer Support Intervention to Optimize PrEP Adherence and Retention in PrEP Care for Youth, National Institutes of Health; National Institute of Mental Health Bart, Bradley – Benefits of uCor…
Read More
New online tool helps transplant candidates find center that best matches individual patient’s criteria
A new website developed by researchers at Hennepin Healthcare Research Institute (HHRI) and the University of Minnesota (UMN) is making it easier for organ transplant candidates to choose which transplant center is right for them. The website, transplantcentersearch.org, was developed for candidates seeking kidney, liver, heart and lung transplants. Data…
Read More
HHRI researchers awarded NIH HEAL Initiative funding to tackle the nation’s opioid crisis
The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is an aggressive, trans-agency effort to accelerate scientific solutions to stop the nation’s opioid crisis. Its research focus is on improving prevention and treatment for opioid misuse and addiction and enhancing pain management. HHRI investigators across disciplines are at…
Read More
ASPREE-XT (eXTension) study receives $42.3 million to determine longer-term effects of aspirin on health
The ASPREE-XT (eXTension)* study was recently awarded $42.3 million in funding from the National Institute On Aging of the National Institutes of Health (NIH). The five-year grant enables researchers to study if there are possible long-term health benefits of being on low-dose aspirin. ASPREE-XT is led by the Berman Center…
Read More- « Previous
- 1
- 2
- 3
- 4
- Next »